Contingency management interventions for abstinence from cigarette smoking in pregnancy and postpartum: A systematic review and meta-analysis
- PMID: 37532032
- PMCID: PMC10828115
- DOI: 10.1016/j.ypmed.2023.107654
Contingency management interventions for abstinence from cigarette smoking in pregnancy and postpartum: A systematic review and meta-analysis
Abstract
Contingency management is one of the most effective treatments for substance use disorders in not-pregnant people. The most recent quantitative review of its efficacy among pregnant and postpartum women who smoke cigarettes concluded with moderate certainty that those receiving contingent financial incentives were twice as likely to be abstinent compared with controls. We aimed to update and extend previous reviews. Five databases were systematically searched for randomized controlled trials (RCTs) published before December 2022 that assessed the effectiveness of incentives for abstinence from substance use. Data from trials of smoking abstinence were pooled using a random-effects meta-analysis model (restricted maximum likelihood). Results are reported as risk-ratios (RRs) with 95% confidence intervals (CIs). This study is registered with PROSPERO, CRD42022372291. Twelve RCTs (3136) pregnant women) were included. There was high certainty evidence that women receiving incentives were more likely to be abstinent than controls at the last antepartum assessment (12 RCTs; RR = 2.43, 95% CI 2.04-2.91, n = 2941, I2 = 0.0%) and moderate certainty evidence at the longest postpartum assessment while incentives were still available (five RCTs; RR = 2.72, 1.47-5.02, n = 659, I2 = 44.5%), and at the longest postpartum follow-up after incentives were discontinued (six RCTs; RR = 1.93, 1.08-3.46, n = 1753, I2 = 51.8%). Pregnant women receiving incentives are twice as likely to achieve smoking abstinence during pregnancy suggesting this intervention should be standard care for pregnant women who smoke. The results also demonstrate that abstinence continues into the postpartum period, including after incentives are discontinued, but more trials measuring outcomes in the postpartum period are needed to strengthen this conclusion.
Keywords: Abstinence; Cigarettes; Contingency management; Incentives; Postpartum; Pregnancy; Smoking; Tobacco.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest to disclose.
Figures
References
-
- The Substance Abuse & Mental Health Data Archive. National Survey on Drug Use and Health (2021): Public-Use Data Analysis System [Internet]. 2023. [cited 2023 Jun 11]. Available from: https://www.datafiles.samhsa.gov/analyze-data
-
- Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018. Jul 1;6(7):e769–76. - PubMed
-
- Wilson CA, Finch E, Kerr C, Shakespeare J. Alcohol, smoking, and other substance use in the perinatal period. BMJ [Internet]. 2020. May 11 [cited 2022 Oct 26];369. Available from: https://www.bmj.com/content/369/bmj.m1627 - PMC - PubMed
-
- Cnattingius S The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine & Tobacco Research [Internet]. 2004. Apr 1 [cited 2022 Oct 25];6(Suppl_2):S125–40. Available from: https://academic.oup.com/ntr/article/6/Suppl_2/S125/1013941 - PubMed
-
- Gould GS, Havard A, Lim LL, Group PSIPE, Kumar R Exposure to tobacco, environmental tobacco smoke and nicotine in pregnancy: a pragmatic overview of reviews of maternal and child outcomes, effectiveness of interventions and barriers and facilitators to quitting. Int J Environ Res Public Health. 2020;17(6):2034. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
